CMS Germany advised BE Investment Partners GmbH and the founders of the Wundex Group.
The private equity investor capiton has acquired a majority stake in the Wundex Group, a leading full-service provider for wound care in Germany.
Capiton acquired the shares in the course of a structured bidding process from the previous majority shareholders BE Investment-Partners GmbH and the founders of the company.
The two founders and managing directors of the group of companies will remain in their position as retroactive shareholders. The closing of the transaction is still subject to the usual approvals by the competent antitrust authorities.
Through the partnership with the investment company capiton, which specializes in medium-sized companies with strong development potential, this growth path will be continued and the successful business strategy of establishing a nationwide care concept for wound treatment in Germany will be consistently pursued.
Wundex is a full-service provider for integrated wound care. For more than 25 years, the companies of the group have specialized in the in-house development of high-quality relief systems in the field of anti-decubitus prophylaxis as well as the distribution of modern wound care products. The focus is on patients with chronic wounds. Thanks to comprehensive consulting services provided by specially trained wound managers and a modern logistics infrastructure, wound patients receive optimal care.
The CMS team, led by Dr Malte Bruhns (Picture) and Dr Thomas Sonnenberg, also included Laura Stein, Dr Tobias Kilian, Dr Dirk Baukholt, Kai Neuhaus, Moritz Pottek, Patricia Jares and Dr Martin Friedberg.
Involved fees earner: Moritz Pottek – CMS DeBacker; Dirk Baukholt – CMS Hasche Sigle; Malte Bruhns – CMS Hasche Sigle; Martin Friedberg – CMS Hasche Sigle; Patricia Jares – CMS Hasche Sigle; Tobias Kilian – CMS Hasche Sigle; Kai Neuhaus – CMS Hasche Sigle; Thomas Sonnenberg – CMS Hasche Sigle; Laura Stein – CMS Hasche Sigle;